Anthony Mancini, See Remarks at Revolution Medicines, Inc. (RVMD), sold 74,900 shares at $93.22 ($7.2M) on 2026-03-25, disclosed to the SEC on 2026-03-26.
Scheduled sale ($7.2M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $93.22 | 1,800 | $168K | 2.3% |
| 2 | $93.22 | 1,800 | $168K | 2.3% |
| 3 | $94.16 | 3,128 | $295K | 4.1% |
| 4 | $94.16 | 3,128 | $295K | 4.1% |
| 5 | $95.49 | 21,086 | $2.0M | 28.1% |
| 6 | $95.49 | 21,086 |
| $2.0M |
| 28.1% |
| 7 | $96.43 | 11,036 | $1.1M | 14.9% |
| 8 | $96.43 | 11,036 | $1.1M | 14.9% |
| 9 | $97.21 | 400 | $39K | 0.5% |
| 10 | $97.21 | 400 | $39K | 0.5% |
| Total | $95.56 avg | 74,900 | $7.2M | 100% |
| Filing → |
| RVMD | SELL | 2026-09-18 | $353K | — | Filing → |
| RVMD | SELL | 2026-09-14 | $3.2M | — | Filing → |
| RVMD | SELL | 2026-06-18 | $720K | — | Filing → |